Rodolphe Clerval
Company: Coave Therapeutics
Job title: Chief Executive Officer
Bio:
Rodolphe has over 20 years’ experience in the pharma and biotech industry. Rodolphe joined Coave Therapeutics in 2020 from Enterome, which he co-founded. Rodolphe has previously worked in business development at TcLand Expression and Genzyme, and as a sell-side equity analyst at Natixis Bank. Rodolphe graduated with a M.Sc. degree in Biochemical Engineering from Polytech Marseille and is a Certified European Financial Analyst from EFFAS-SFAF.
Seminars:
Highlighting Better Tissue-Specificity Development Efforts for IV-Administered Vectors 11:00 am
Improving capsid and payload design efforts to increase tissue specificity Decreasing vector sequestration by the liver: does liver de-targeting impact extrahepatic biodistribution? Highlighting detargeting efforts of other off-target tissues (e.g. DRG detargeting for CNS targeted capsids)Read more
day: Conference Day One
Delve into the Latest Understanding of Capsid Structure-Function Relationships to Generate Tissue-Specific and Immune-Evading Capsids 3:01 pm
day: Conference Day One